UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

Cephalalgia, 2008-04, Vol.28 (4), p.383-391

2008

Volltextzugriff (PDF)

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Neurología (Barcelona, English ed. ), 2022-06, Vol.37 (5), p.390-402

2022

Volltextzugriff (PDF)

Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

Neurología (Barcelona, English ed. ), 2022-06, Vol.37 (5), p.390-402

2022

Volltextzugriff (PDF)

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Volltextzugriff (PDF)

One-year prevalence of migraine in Spain: A nationwide population-based survey

Cephalalgia, 2011-03, Vol.31 (4), p.463-470

2011

Volltextzugriff (PDF)

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

Neurología (Barcelona, English ed. ), 2023-04

2023

Volltextzugriff (PDF)

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology’s Headache Study Group

Neurología (Barcelona, English ed. ), 2024-02

2024

Volltextzugriff (PDF)

PND99 The Humanistic Disease Burden of Episodic and Chronic Migraine in France, Spain and the United Kingdom

Value in health, 2020-12, Vol.23, p.S640-S641

2020

Volltextzugriff (PDF)

Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients

Neurología (Barcelona, Spain), 2006-05, Vol.21 (4), p.188-191

2006

Volltextzugriff (PDF)

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

Revista de neurologiá, 2024-01, Vol.78 (2), p.47

2024

Volltextzugriff (PDF)

Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

Lancet neurology, 2012-05, Vol.11 (5), p.405-413

2012

Volltextzugriff (PDF)

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress

Revista de neurologiá, 2021-06, Vol.72, p.S1-S19

2021

Volltextzugriff (PDF)

Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)

Revista de neurologiá, 2013-02, Vol.56 (3), p.143-151

2013

Volltextzugriff (PDF)

Neurocutaneous melanosis

Revista de neurologiá, 1998-05, Vol.26 (153), p.769-771

1998

Volltextzugriff (PDF)

Caracterización del manejo del paciente con migraña en Atención Primaria en España. Análisis de los resultados del proyecto europeo My-LIFE anamnesis

Neurología (Barcelona, Spain), 2023-06, Vol.38, p.S22-S30

2023

Volltextzugriff (PDF)

Headache and wine. Are all wines the same?

Journal of headache and pain, 2013-02, Vol.14 (Suppl 1), p.P32-P32, Article P32

2013

Volltextzugriff (PDF)

Headache and wine. Are all wines the same?

Journal of headache and pain, 2013-02, Vol.1 Suppl 1, p.P32-P32

2013

Volltextzugriff (PDF)

Headache and wine. Are all wines the same?: Doc 371

Journal of headache and pain, 2013-02, Vol.14, p.1

2013

Volltextzugriff (PDF)

CGRP en migraña: de la fisiopatología a la terapéutica

Neurología (Barcelona, Spain), 2022-06, Vol.37 (5), p.390-402

2022

Volltextzugriff (PDF)

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Volltextzugriff (PDF)

Idiopathic intracranial hypertension associated with inferior vena cava thrombosis and protein S deficiency

Revista de neurologiá, 2002-02, Vol.34 (4), p.398

2002

Volltextzugriff (PDF)

Familial amyloid polyneuropathy: two new cases of late onset, with many asymptomatic carriers in the family

Revista de neurologiá, 2001-09, Vol.33 (5), p.494-495

2001

Volltextzugriff (PDF)

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Neurología (Barcelona, English ed. ), 2022-06, Vol.37 (5), p.390

2022

Volltextzugriff (PDF)

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy: Efficacy of almotriptan in treatment of acute migraine

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaTriptans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)
Berichte
(1)

Sprache

Spanisch
(22)
Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

One-year prevalence of migraine in Spain: A nationwide population-based survey

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology’s Headache Study Group

PND99 The Humanistic Disease Burden of Episodic and Chronic Migraine in France, Spain and the United Kingdom

Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress

Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)

Neurocutaneous melanosis

Caracterización del manejo del paciente con migraña en Atención Primaria en España. Análisis de los resultados del proyecto europeo My-LIFE anamnesis

Headache and wine. Are all wines the same?

Headache and wine. Are all wines the same?

Headache and wine. Are all wines the same?: Doc 371

CGRP en migraña: de la fisiopatología a la terapéutica

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study

Idiopathic intracranial hypertension associated with inferior vena cava thrombosis and protein S deficiency

Familial amyloid polyneuropathy: two new cases of late onset, with many asymptomatic carriers in the family

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy: Efficacy of almotriptan in treatment of acute migraine

Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

Aktive Filter

Suchergebnisse filtern